Influence of comorbidity on survival, toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy-Reference-Cited by-同舟云学术

Influence of comorbidity on survival, toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy

Published:2010-08 Issue:12 Volume:46 Page:2225-2234
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Grønberg Bjørn H.,Sundstrøm Stein,Kaasa Stein,Bremnes Roy M.,Fløtten Øystein,Amundsen Tore,Hjelde Harald H.,Plessen Christian von,Jordhøy Marit

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference30 articles.

1. Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials. J Clin Oncol 2008;26:4617–25.

2. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003;Pfister;J Clin Oncol,2004

3. Trends and predictors of first-line chemotherapy use among elderly patients with advanced non-small cell lung cancer in the United States;Lang;Lung Cancer,2009

4. Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E1594: a phase II trial in patients with metastatic nonsmall cell lung carcinoma;Sweeney;Cancer,2001

5. Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trials;Vardy;BMC Cancer,2009

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early Changes in Nutritional Status of Elderly Patients with Lung Cancer Undergoing Chemotherapy Are Positively Related with Symptoms of Depression: A Prospective Follow-Up Study;Nutrition and Cancer;2024-07-07

2. Prediction of moderate and severe toxicities of chemotherapy in older patients with cancer: a propensity weighted analysis of ELCAPA cohort;The Oncologist;2024-07-06

3. Prognostic impact of clinical factors for immune checkpoint inhibitor with or without chemotherapy in older patients with non-small cell lung cancer and PD-L1 TPS ≥ 50%;Frontiers in Immunology;2024-02-23

4. Lung cancer, comorbidities, and medication: the infernal trio;Frontiers in Pharmacology;2024-02-21

5. Comorbidities in the Cancer Patient;Tata Memorial Centre Textbook of Oncology;2024